Casandra
Casandra Test Code QD09482Version 1 (DRAFT)
Performing Lab
SurePath™ Imaging Pap and HPV mRNA E6/E7, C. trachomatis, N. gonorrhoeae
Clinical Use
Order TestUse
Combined cytologic evaluation via image‑guided Papusing SurePath™ along with detection of high‑risk HPV E6/E7 mRNA and screening for Chlamydia trachomatis and Neisseria gonorrhoeae supports comprehensive cervical cancer and STI screening in a single specimen.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
4 components
SurePath Imaging Pap cytology • Automated AnalyzerHPV mRNA E6/E7 assay • RT-qPCRChlamydia trachomatis RNA test • PCRNeisseria gonorrhoeae RNA test • PCR
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tumor Tissue
Volume
Not provided
Minimum Volume
Not provided
Container
SurePath™ pap vial
Collection Instructions
Pap sample collected in 1 (1 minimum) SurePath™ pap vial
Causes for Rejection
SurePath™ vials without the head of the collection device(s) in the fluid; SurePath™ vials received frozen; swabs; cervical swabs in Digene® HC cervical sampler, Digene® vials